跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
CISPLATIN INJECTION BP
Authorized
STANDARD
CISPLATIN INJECTION BP
hikma canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
d5f63af1f8133dd7
Company
hikma canada limited
Type
Standard
Approval Details
Approval Id
d5f63af1f8133dd7
Drug Approval Canada Name
CISPLATIN INJECTION BP
Product Name
CISPLATIN INJECTION BP
Status
Marketed
Status Date
2024-02-23
Original Market Date
2024-02-23
Din
02536285
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01XA01 CISPLATIN
Atc Name
l 01 xa 01
Aig Number
0113245002
Company Name
hikma canada limited
Company Address
5995 Avebury Road, Suite 804, Mississauga, Ontario, Canada, L5R 3P9
Active Ingredients
CISPLATIN
1 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
d5f63af1f8133dd7
Type
Standard
Back to Health Canada Approvals
CISPLATIN INJECTION BP - Health Canada Drug Approval Details